Olaplex (NASDAQ:OLPX – Get Free Report) had its price target upped by investment analysts at Barclays from $1.50 to $1.70 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s target price points to a potential upside of 1.19% from the company’s current price.
OLPX has been the topic of a number of other reports. Telsey Advisory Group restated a “market perform” rating and issued a $2.00 price target on shares of Olaplex in a research note on Tuesday. Piper Sandler raised their target price on shares of Olaplex from $1.50 to $2.00 and gave the company a “neutral” rating in a research report on Monday, January 6th.
Read Our Latest Stock Analysis on OLPX
Olaplex Stock Up 21.7 %
Institutional Trading of Olaplex
Several hedge funds and other institutional investors have recently made changes to their positions in OLPX. Chemistry Wealth Management LLC bought a new position in Olaplex in the 4th quarter valued at approximately $25,000. Cinctive Capital Management LP acquired a new position in Olaplex in the 3rd quarter valued at approximately $38,000. Abel Hall LLC raised its stake in shares of Olaplex by 68.1% during the third quarter. Abel Hall LLC now owns 18,261 shares of the company’s stock valued at $43,000 after acquiring an additional 7,397 shares during the last quarter. Hsbc Holdings PLC acquired a new position in shares of Olaplex during the fourth quarter worth $34,000. Finally, BNP Paribas Financial Markets acquired a new position in Olaplex during the 4th quarter worth about $35,000. 87.37% of the stock is currently owned by institutional investors.
Olaplex Company Profile
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
See Also
- Five stocks we like better than Olaplex
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Raytheon vs. Lockheed Martin: Which Stock Has More Upside?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Grab Holdings: Time to Grab More of This Rideshare Beast
- How to Choose Top Rated Stocks
- Okta’s Stock Reversal Gains Momentum—20% Upside Ahead
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.